$NTRA
Natera, Inc.

2021 Q3 Form 10-Q Financial Statement

#000155837021010673 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $158.1M $142.0M $86.47M
YoY Change 61.11% 64.25% 16.3%
Cost Of Revenue $81.37M $76.11M $42.73M
YoY Change 57.09% 78.12% 3.26%
Gross Profit $76.75M $65.91M $43.74M
YoY Change 65.76% 50.69% 43.27%
Gross Profit Margin 48.54% 46.41% 50.58%
Selling, General & Admin $128.5M $127.5M $68.19M
YoY Change 69.78% 86.92% 44.95%
% of Gross Profit 167.42% 193.37% 155.89%
Research & Development $98.46M $53.75M $23.01M
YoY Change 272.65% 133.65% 89.75%
% of Gross Profit 128.29% 81.55% 52.59%
Depreciation & Amortization $2.997M $2.712M $2.210M
YoY Change 37.48% 22.71% -44.08%
% of Gross Profit 3.91% 4.11% 5.05%
Operating Expenses $226.9M $181.2M $91.19M
YoY Change 122.28% 98.71% 54.13%
Operating Profit -$150.2M -$115.3M -$51.66M
YoY Change 169.28% 123.18% 80.4%
Interest Expense $2.078M $2.075M $4.038M
YoY Change -51.33% -48.61% 48.4%
% of Operating Profit
Other Income/Expense, Net $1.274M $1.585M $1.900M
YoY Change -25.06% -16.58% 137.5%
Pretax Income -$151.0M -$115.8M -$59.62M
YoY Change 159.02% 94.2% 95.35%
Income Tax $272.0K $242.0K $15.00K
% Of Pretax Income
Net Earnings -$151.3M -$116.0M -$59.64M
YoY Change 159.37% 94.55% 83.97%
Net Earnings / Revenue -95.67% -81.69% -68.97%
Basic Earnings Per Share -$1.63 -$1.32
Diluted Earnings Per Share -$1.634M -$1.32 -$753.5K
COMMON SHARES
Basic Shares Outstanding 93.78M 88.08M 78.73M
Diluted Shares Outstanding 92.56M 88.08M

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.024B $580.2M $571.2M
YoY Change 26.45% 1.58% 140.0%
Cash & Equivalents $95.10M $62.81M $77.32M
Short-Term Investments $928.6M $517.4M $493.9M
Other Short-Term Assets $29.09M $31.11M $15.60M
YoY Change 88.87% 99.4% 168.97%
Inventory $28.02M $28.41M $18.03M
Prepaid Expenses
Receivables $110.4M $100.1M $58.71M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.191B $739.9M $663.5M
YoY Change 30.04% 11.51% 106.06%
LONG-TERM ASSETS
Property, Plant & Equipment $59.29M $48.88M $25.93M
YoY Change 109.89% 88.56% -46.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.20M $12.85M $12.36M
YoY Change 8.6% 3.97% -5.67%
Total Long-Term Assets $120.2M $110.1M $59.76M
YoY Change 97.94% 84.19% -2.52%
TOTAL ASSETS
Total Short-Term Assets $1.191B $739.9M $663.5M
Total Long-Term Assets $120.2M $110.1M $59.76M
Total Assets $1.311B $850.0M $723.3M
YoY Change 34.26% 17.52% 88.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.181M $20.31M $3.450M
YoY Change -11.56% 488.61% -58.43%
Accrued Expenses $96.49M $86.14M $53.08M
YoY Change 53.41% 62.28% 38.23%
Deferred Revenue $9.667M $10.65M $52.39M
YoY Change -81.13% -79.68%
Short-Term Debt $50.00M $50.00M $50.10M
YoY Change -0.2% -0.2% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $199.7M $198.0M $175.6M
YoY Change 1.96% 12.78% 38.35%
LONG-TERM LIABILITIES
Long-Term Debt $280.1M $279.8M $197.5M
YoY Change 40.04% 41.66% 168.71%
Other Long-Term Liabilities $1.464M $73.08M $310.0K
YoY Change 372.26% 23474.52% -99.65%
Total Long-Term Liabilities $1.464M $352.9M $310.0K
YoY Change 372.26% 113725.16% -99.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $199.7M $198.0M $175.6M
Total Long-Term Liabilities $1.464M $352.9M $310.0K
Total Liabilities $552.4M $550.8M $419.0M
YoY Change 25.33% 31.47% 44.38%
SHAREHOLDERS EQUITY
Retained Earnings -$1.300B -$1.100B -$794.6M
YoY Change 52.42% 38.43%
Common Stock $2.012B $1.400B $1.093B
YoY Change 45.39% 28.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $759.0M $299.1M $304.3M
YoY Change
Total Liabilities & Shareholders Equity $1.311B $850.0M $723.3M
YoY Change 34.26% 17.52% 88.69%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$151.3M -$116.0M -$59.64M
YoY Change 159.37% 94.55% 83.97%
Depreciation, Depletion And Amortization $2.997M $2.712M $2.210M
YoY Change 37.48% 22.71% -44.08%
Cash From Operating Activities -$91.06M -$70.56M -$40.98M
YoY Change 174.86% 72.18% 14.63%
INVESTING ACTIVITIES
Capital Expenditures -$17.41M -$8.631M -$2.210M
YoY Change 797.27% 290.54% -238.21%
Acquisitions
YoY Change
Other Investing Activities -$414.0M $68.60M -$163.2M
YoY Change 281.92% -142.03% 44.11%
Cash From Investing Activities -$431.4M $59.97M -$165.4M
YoY Change 290.94% -136.25% 63.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $551.2M
YoY Change 103.39%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 554.8M 8.344M 209.6M
YoY Change 101.28% -96.02% 81.12%
NET CHANGE
Cash From Operating Activities -91.06M -70.56M -40.98M
Cash From Investing Activities -431.4M 59.97M -165.4M
Cash From Financing Activities 554.8M 8.344M 209.6M
Net Change In Cash 32.29M -2.246M 3.180M
YoY Change -75.56% -170.63% -115.13%
FREE CASH FLOW
Cash From Operating Activities -$91.06M -$70.56M -$40.98M
Capital Expenditures -$17.41M -$8.631M -$2.210M
Free Cash Flow -$73.65M -$61.93M -$38.77M
YoY Change 136.15% 59.73% 3.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86223000
dei Entity Registrant Name
EntityRegistrantName
Natera, Inc.
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0001604821
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
88498000
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Entity File Number
EntityFileNumber
001-37478
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0894487
dei Entity Address Address Line1
EntityAddressAddressLine1
13011 McCallen Pass
dei Entity Address Address Line2
EntityAddressAddressLine2
Building A Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78753
dei City Area Code
CityAreaCode
650
us-gaap Costs And Expenses
CostsAndExpenses
267016000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19374000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4851000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-403000
us-gaap Net Income Loss
NetIncomeLoss
-95009000
dei Local Phone Number
LocalPhoneNumber
249-9090
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48337000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
739888000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
862663000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48884000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33348000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
NTRA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
93783076
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62811000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48668000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
228000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
187000
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
517432000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
688606000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2649000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3080000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100130000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78565000
CY2021Q2 us-gaap Inventory Net
InventoryNet
28409000
CY2020Q4 us-gaap Inventory Net
InventoryNet
20031000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30878000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26606000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21399000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12847000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14743000
CY2021Q2 us-gaap Assets
Assets
849956000
CY2020Q4 us-gaap Assets
Assets
932153000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
20307000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8096000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30842000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30371000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86143000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60407000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10647000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
50125000
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
50049000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
50054000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
197988000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
199053000
CY2021Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
279777000
CY2020Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
202493000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23562000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22805000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49519000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21246000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
320000
CY2021Q2 us-gaap Liabilities
Liabilities
550846000
CY2020Q4 us-gaap Liabilities
Liabilities
445917000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88498000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86223000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
9000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1399659000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1411286000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1102999000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-929318000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2441000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4259000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
299110000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
486236000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
849956000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
932153000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142026000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294342000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53752000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23005000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93940000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41230000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
127456000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
68188000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
235788000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133869000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
257320000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
138132000
us-gaap Costs And Expenses
CostsAndExpenses
472653000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-115294000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-51660000
us-gaap Operating Income Loss
OperatingIncomeLoss
-178311000
us-gaap Operating Income Loss
OperatingIncomeLoss
-86532000
CY2021Q2 us-gaap Interest Expense
InterestExpense
2075000
CY2020Q2 us-gaap Interest Expense
InterestExpense
4038000
us-gaap Interest Expense
InterestExpense
4148000
us-gaap Interest Expense
InterestExpense
6502000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1585000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1924000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2956000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3911000
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115784000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59622000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-179503000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-94971000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
242000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
376000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-116026000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-59637000
us-gaap Net Income Loss
NetIncomeLoss
-179879000
us-gaap Net Income Loss
NetIncomeLoss
-95009000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-756000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
104000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1818000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4851000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116782000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59533000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-181697000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-90158000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
88077000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79069000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87387000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78681000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
258927000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6981000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11957000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
104000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-59637000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
278711000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10808000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3062000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
82873000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
304267000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
372445000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2259000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6085000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35103000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-756000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-116026000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
299110000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
486236000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6829000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6085000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
58335000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-1818000
ntra Cumulative Effect Of New Accounting Principle In Period Of Adoption Duration
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoptionDuration
-76678000
us-gaap Net Income Loss
NetIncomeLoss
-179879000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
299110000
us-gaap Profit Loss
ProfitLoss
-179879000
us-gaap Profit Loss
ProfitLoss
-95009000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5262000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4036000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
3790000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1887000
us-gaap Gain Loss On Investments
GainLossOnInvestments
35000
us-gaap Share Based Compensation
ShareBasedCompensation
58335000
us-gaap Share Based Compensation
ShareBasedCompensation
19374000
us-gaap Operating Lease Cost
OperatingLeaseCost
5357000
us-gaap Operating Lease Cost
OperatingLeaseCost
3880000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
610000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2180000
us-gaap Inventory Write Down
InventoryWriteDown
612000
ntra Other Non Cash Benefits Charges
OtherNonCashBenefitsCharges
117000
ntra Other Non Cash Benefits Charges
OtherNonCashBenefitsCharges
-341000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
63000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1445000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5848000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21628000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5972000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8991000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5410000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7466000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5610000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
23000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-99000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12313000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4684000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
471000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
495000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
24374000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
6602000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-38721000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-145439000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76080000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
71054000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
266139000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
31144000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
11500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
205510000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
142815000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18891000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10130000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
146709000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121954000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6829000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10808000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
6085000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
3062000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
278317000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
78757000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12914000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213430000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
14184000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15396000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48855000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61981000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63039000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77377000
us-gaap Interest Paid Net
InterestPaidNet
3538000
us-gaap Interest Paid Net
InterestPaidNet
2976000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4688000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
255000
us-gaap Net Income Loss
NetIncomeLoss
-179900000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1100000000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63000000.0
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
517400000
CY2021Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
50000000.0
CY2021Q2 us-gaap Other Commitment
OtherCommitment
10000000
CY2021Q2 ntra Payments For Third Party Assets If Purchase Option Exercised
PaymentsForThirdPartyAssetsIfPurchaseOptionExercised
290000000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:40.3pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in accordance with generally accepted accounting principles (GAAP) in the United States requires management to make estimates and assumptions about future events that affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenues and expenses. Significant items subject to such estimates include the allowance for doubtful accounts calculated based on the average selling price expected to be received from insurance payors, the operating right-of-use assets and the associated lease liabilities, deferred revenues associated with unsatisfied performance obligations, accrued liability for potential refund requests, the valuation of the Convertible Notes, stock-based compensation, the fair value of common stock, income tax uncertainties, and the expected consideration to be received from contracts with customers. These estimates and assumptions are based on management's best estimates and judgment. Management regularly evaluates its estimates and assumptions using historical experience and other factors, including contractual terms and statutory limits; however, actual results could differ from these estimates and could have an adverse effect on the Company's financial statements.</p>
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4220000
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
63000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
495000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3788000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:10pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Risk and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company is subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict, and the full extent and duration of the impact of the COVID-19 pandemic on its business, its operations, and the global economy as a whole is not yet known. While the Company’s test volumes and overall average selling prices for its tests increased during the six months ended June 30, 2021 compared to the six months ended June 30, 2020, the Company cannot predict the potential nature, magnitude and duration of the effects of the COVID-19 pandemic on the macroeconomic environment or its business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist of cash, accounts receivable and investments. The Company limits its exposure to credit loss by placing its cash in financial institutions with high credit ratings. The Company's cash may consist of deposits held with banks that may at times exceed federally insured limits. The Company performs evaluations of the relative credit standing of these financial institutions and limits the amount of credit exposure with any one institution. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company performs evaluations of financial conditions for insurance carriers, patients, clinics and laboratory partners and generally does not require collateral to support credit sales. For the six months ended June 30, 2021, and 2020, there were no customers exceeding 10% of total revenues on an individual basis. As of June 30, 2021 and December 31, 2020, there were no customers with an outstanding balance exceeding 10% of net accounts receivable. </p>
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3197000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5666000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4259000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
919000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2441000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5770000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2441000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5770000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142026000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294342000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
142026000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86472000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294342000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
180484000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100130000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78565000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10647000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
50125000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23562000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
22805000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34209000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
72930000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
72930000
ntra Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3474000
ntra Contract With Customer Liability Refunds Of Revenues Previously Deferred
ContractWithCustomerLiabilityRefundsOfRevenuesPreviouslyDeferred
10000000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-30839000
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-1356000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34209000
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-30800000
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
31100000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11500000
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
23
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
213114000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
213493000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
301877000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
303939000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
514991000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
517432000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
104201000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83402000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55317000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50054000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48884000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33348000
us-gaap Depreciation
Depreciation
5300000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3325000
CY2021Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4364000
CY2020Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4189000
CY2021Q2 ntra Accrued Shipping Charges
AccruedShippingCharges
1276000
CY2021Q2 ntra Deposits Held For Sublease
DepositsHeldForSublease
10000
CY2021Q2 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
19041000
CY2020Q4 ntra Other Accrued Sundry Expenses Current
OtherAccruedSundryExpensesCurrent
9562000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86143000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60407000
CY2021Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2439000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2260000
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
14104000
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
12686000
CY2021Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
7984000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9635000
CY2021Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
6315000
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
5790000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30842000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30371000
CY2021Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
22301000
CY2020Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
17366000
CY2021Q2 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
10422000
CY2020Q4 ntra Accrued Charges For Outsourced Testing
AccruedChargesForOutsourcedTesting
5141000
CY2021Q2 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
7805000
CY2020Q4 ntra Accrued Testing And Laboratory Materials From Suppliers
AccruedTestingAndLaboratoryMaterialsFromSuppliers
2720000
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5374000
CY2020Q4 ntra Accrued Shipping Charges
AccruedShippingCharges
1604000
CY2021Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1501000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
1723000
CY2021Q2 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2482000
CY2020Q4 ntra Accrued Specimen Service Fees
AccruedSpecimenServiceFees
2355000
CY2021Q2 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
2419000
CY2020Q4 ntra Accrued Clinical Trials And Studies
AccruedClinicalTrialsAndStudies
2353000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6330000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7300000
CY2021Q2 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1740000
CY2020Q4 ntra Accrued Fixed Asset Purchases
AccruedFixedAssetPurchases
1691000
CY2021Q2 ntra Accrued Interest
AccruedInterest
1078000
CY2020Q4 ntra Accrued Interest
AccruedInterest
1078000
CY2020Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
17366000
CY2019Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
9410000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
10960000
ntra Insurance Carrier Reserves Additions
InsuranceCarrierReservesAdditions
8563000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
3054000
ntra Insurance Refunds To Carriers
InsuranceRefundsToCarriers
3251000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
2971000
ntra Insurance Carrier Reserves Released
InsuranceCarrierReservesReleased
1622000
CY2021Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
22301000
CY2020Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
13100000
ntra Noncash Investing Activities Related To Right Of Use Assets
NoncashInvestingActivitiesRelatedToRightOfUseAssets
30100000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6330000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
49519000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
55849000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0749
CY2021Q2 us-gaap Lease Cost
LeaseCost
2700000
CY2020Q2 us-gaap Lease Cost
LeaseCost
1900000
us-gaap Lease Cost
LeaseCost
5400000
us-gaap Lease Cost
LeaseCost
3900000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2500000
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2200000
us-gaap Operating Lease Payments
OperatingLeasePayments
5000000.0
us-gaap Operating Lease Payments
OperatingLeasePayments
4400000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5086000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10404000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11889000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
11071000
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q2 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12186000
CY2021Q2 ntra Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
20064000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
70700000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14851000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
55849000
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
62722000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
242000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
376000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000
us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12900000
CY2021Q2 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-116026000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11500000
CY2020Q2 ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-59637000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-179879000
ntra Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-95009000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
88077000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
79069000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
87387000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78681000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.75
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17718000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19335000

Files In Submission

Name View Source Status
0001558370-21-010673-index-headers.html Edgar Link pending
0001558370-21-010673-index.html Edgar Link pending
0001558370-21-010673.txt Edgar Link pending
0001558370-21-010673-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntra-20210630.xsd Edgar Link pending
ntra-20210630x10q.htm Edgar Link pending
ntra-20210630x10q_htm.xml Edgar Link completed
ntra-20210630xex31d1.htm Edgar Link pending
ntra-20210630xex31d2.htm Edgar Link pending
ntra-20210630xex32d1.htm Edgar Link pending
ntra-20210630xex32d2.htm Edgar Link pending
ntra-20210630_cal.xml Edgar Link unprocessable
ntra-20210630_def.xml Edgar Link unprocessable
ntra-20210630_lab.xml Edgar Link unprocessable
ntra-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending